Altered States Psychedelics on the Ballot
4 snips
Oct 2, 2024 Graham Boyd is an attorney and drug policy strategist, instrumental in shaping state-level cannabis and psychedelic initiatives. Alongside journalist Damiano Marchetti, they delve into Oregon's psilocybin journey, contrasting successes and setbacks with Measure 110. Boyd shares insights from the cannabis campaign, including the importance of gradual, regulated rollouts to avoid backlash and how to effectively frame psychedelics within a mental health context. They explore the potential future of psychedelics, including the risks and therapeutic focus that could differentiate it from cannabis.
AI Snips
Chapters
Transcript
Episode notes
Small Psychedelic Win Amid Broader Failures
- Oregon's psilocybin measure succeeded despite a simultaneous, failing decriminalization experiment.
- Public perception depended on careful framing and implementation, not just novelty.
A Lifelong Commitment To Compassion
- Graham Boyd recounts his lifelong work shifting drug policy toward compassion and public health.
- He says it's heartbreaking when reforms don't achieve their intended outcomes.
Cannabis Playbook Scaled State-by-State
- Boyd mapped a repeatable playbook for state-level drug ballot campaigns from cannabis work.
- That playbook relied on targeted messaging and coordinated, well-funded efforts to create a domino effect.